Treatment options in non-muscle-invasive bladder cancer after BCG failure

about

Autophagy and urothelial carcinoma of the bladder: A review Role of Non-Coding RNAs in the Etiology of Bladder Cancer.Use of photodynamic inactivation for in vitro reduction of prevalent bacteria in Fournier's Gangrene.

P2860

Q26744142-A0FFAE7D-901A-49F3-ACE1-C06D3C666C0B Q46236214-5320A68D-CF4D-4396-BA08-89FB15EF2BE8 Q50014337-032E2A69-3B69-43F6-8044-12C99ADEC326

P2860

Treatment options in non-muscle-invasive bladder cancer after BCG failure

Item

http://www.wikidata.org/entity/Q26775977

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@ast

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@en

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@nl

type

Item

label

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@ast

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@en

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@nl

prefLabel

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@ast

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@en

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@nl

P1476

Treatment options in non-muscle-invasive bladder cancer after BCG failure

@en

P2093

Michael A O'Donnell

http://www.w3.org/2001/XMLSchema#string

Nathan A Brooks

http://www.w3.org/2001/XMLSchema#string

P2860

Intravesical gemcitabine for non-muscle invasive bladder cancer

Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo working party

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study.

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

Mitomycin C: mechanism of action, usefulness and limitations.

Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy.

Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer.

SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guérin

Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma.

P304

312-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

876493

http://www.w3.org/2001/XMLSchema#string

P356

10.4103/0970-1591.166475

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M A O'Donnell

Nathan A Brooks

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26604442

http://www.w3.org/2001/XMLSchema#string

P932

4626915

http://www.w3.org/2001/XMLSchema#string

Treatment options in non-muscle-invasive bladder cancer after BCG failure

about

P2860

P2860

Treatment options in non-muscle-invasive bladder cancer after BCG failure

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P932

P3181

P356

P1433

P1476

P2093

P2860

P304

P31

P3181

P356

P407

P433

P478

P50

P577

P698

P932